Nighttime salivary cortisol: a useful test for the diagnosis of Cushing's syndrome.
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Clinical features such as weight gain, depression, hypertension, and menstrual irregularities, although common in the general population, may raise the possibility of Cushing's syndrome. Up to 30% of urine cortisol and dexamethasone suppression screening tests may return an incorrect result, suggesting that better tests are needed. This study evaluated the utility of nighttime salivary cortisol measurement as a screening test for Cushing's syndrome. We evaluated 139 inpatients and 4 outpatients with possible Cushing's syndrome, 16 inpatients and 7 outpatients with other nonadrenal disorders, and 34 healthy outpatients. Using cut points that excluded all subjects without Cushing's syndrome, we compared the sensitivity for the detection of Cushing's syndrome of nighttime salivary cortisol levels (2330 and 2400 h for inpatients and bedtime for outpatients), simultaneous inpatient serum cortisol levels, and urine glucocorticoid excretion. An assay- specific inpatient 2400-h salivary cortisol or an outpatient bedtime salivary cortisol greater than 550 ng/dl (15.2 nmol/liter) identified 93% of patients with Cushing's syndrome (confidence interval, 89-98%) and excluded all individuals without the disorder. Salivary cortisol measurements worked as well as plasma measurements and better than urine glucocorticoid excretion. We concluded that bedtime salivary cortisol measurement is a practical and accurate screening test for the diagnosis of Cushing's syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Using a variety of assays and diagnostic criteria, investigators from different countries have reported that late-night salivary cortisol levels yield a 92-100% sensitivity and a 93-100% specificity for the diagnosis of Cushing's syndrome (59 -67).”
From The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. (2008) · cites this paper as [62]
In the citing paper
“Various methods have been used to measure cortisol in the saliva, resulting in different reference ranges and yielding differences in sensitivity and specificity (59 -67).”
From The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. (2008) · cites this paper as [62]
Citations
Cites
The Diagnosis and Differential Diagnosis of Cushing’s Syndrome and Pseudo-Cushing’s States
Newell-Price, J., Trainer, P., Besser, M., & Grossman, A. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0346 · Cited by 833
Gold, P. W., Loriaux, D. L., Roy, A., Kling, M. A., Calabrese, J. R., Kellner, C. H., Nieman, L. K., Post, R. M., Pickar, D., Gallucci, W., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198605223142101 · Cited by 766
Self-citationOrth, D. N. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503233321207 · Cited by 576
Characterization of the normal temporal pattern of plasma corticosteroid levels.
KRIEGER, D. T., ALLEN, W., RIZZO, F., & KRIEGER, H. P. (1971) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-32-2-266 · Cited by 549 · cited 1×
“We previously exploited the preservation of the physiologic circadian rhythmicity of cortisol secretion (15) in pseudo-Cushing states, compared with Cushing’s syndrome, showing that serum cortisol measurement at 2400 h can distinguish the two conditions with a diagnostic accuracy of 95% (16).”
BackgroundCushing's syndrome: a review of diagnostic tests.
Crapo, L. (1979) · Metabolism · doi:10.1016/0026-0495(79)90097-0 · Cited by 393 · cited 1×
“The 1-mg overnight dexamethasone suppression test (DST) (7) is simple and inexpensive, but it has a false positive rate of up to 30%, especially in chronic illness, obesity, and psychiatric disorders (8, 9) and even in healthy individuals (10).”
BackgroundSalivary cortisol measurement: a practical approach to assess pituitary-adrenal function.
LAUDAT, M. H., CERDAS, S., FOURNIER, C., GUIBAN, D., GUILHAUME, B., & LUTON, J. P. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-2-343 · Cited by 393 · cited 2×
“in studies using Salivette (103 ng/dl) (29) and direct collection (86–112 ng/dl) (20, 27) suggests that collection tech-”
BackgroundPearson Murphy, B. E. (1991) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(91)90312-s · Cited by 244
A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome
Newell‐Price, J., Trainer, P., Perry, L., Wass, J., Grossman, A., & Besser, M. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02918.x · Cited by 229
Papanicolaou, D. A., Yanovski, J. A., Cutler, G. B., Chrousos, G. P., & Nieman, L. K. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.4.4733 · Cited by 201
Self-citationMEIKLE, A. W. (1982) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1982.tb00733.x · Cited by 201 · cited 1×
“alcohol, rifampin, phenytoin, phenobarbital) that induce the cytochrome P450-related enzymes, which enhance dexamethasone clearance, and in patients with renal or hepatic failure, which retard dexamethasone clearance (13, 14).”
BackgroundLate-night salivary cortisol as a screening test for cushing's syndrome
Raff, H. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.8.2681 · Cited by 194 · cited 2×
“Twenty-eight samples were run a second time in the same assay and at the same time in a second assay, the Coat-a-Count assay (Diagnostic Products, Los Angeles, CA) as modified by other authors for saliva (18).”
BackgroundMethodALCOHOL-INDUCED PSEUDO-CUSHING'S SYNDROME
Rees, L. H., Besser, G. M., Jeffcoate, W. J., Goldie, D. J., & Marks, V (1977) · The Lancet · doi:10.1016/s0140-6736(77)92169-9 · Cited by 192
Castro, M., Elias, P. C. L., Quidute, A. R. P., Halah, F. P. B., & Moreira, A. C. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.3.5521 · Cited by 151
Five cases of cyclical Cushing's syndrome.
Atkinson, A. B., Kennedy, A. L., Carson, D. J., Hadden, D. R., Weaver, J. A., & Sheridan, B. (1985) · BMJ · doi:10.1136/bmj.291.6507.1453 · Cited by 129
Gafni, R. I., Papanicolaou, D. A., & Nieman, L. K. (2000) · The Journal of Pediatrics · doi:10.1067/mpd.2000.106226 · Cited by 115
Self-citationSalivary cortisol for screening of Cushing's syndrome in children.
Martinelli, C. E., Sader, S. L., Oliveira, E. B., Daneluzzi, J. C., & Moreira, A. C. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00749.x · Cited by 114 · cited 1×
“in studies using Salivette (103 ng/dl) (29) and direct collection (86–112 ng/dl) (20, 27) suggests that collection tech-”
BackgroundA Rapid Screening Test for Cushing's Syndrome
Pavlatos, F. C. (1965) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1965.03090090026005 · Cited by 104
Diabetic neuropathy is associated with increased activity of the hypothalamic-pituitary-adrenal axis
Tsigos, C. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.3.554 · Cited by 79
Comparison of Two Methods for Measuring Salivary Cortisol
Raff, H., Homar, P. J., & Burns, E. A. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.1.207 · Cited by 74
Salivary cortisol for the evaluation of Cushing's syndrome.
Luthold, W. W., Marcondes, J. A. M., & Wajchenberg, B. L. (1985) · Clinica Chimica Acta · doi:10.1016/0009-8981(85)90232-3 · Cited by 56 · cited 1×
“Several investigators have shown that mean 2400-h salivary cortisol concentrations are higher in Cushing’s syndrome than in normal individuals (24, 27, 28, 31, 32), and three studies (18–20) have shown that obese patients or individuals suspected of having Cushing’s syndrome can be distinguished from patients with the…”
BackgroundSALIVARY CORTISOL LEVELS IN TRUE AND APPARENT HYPERCORTISOLISM
EVANS, P. J., PETERS, J. R., DYAS, J., WALKER, R. F., RIAD‐FAHMY, D., & HALL, R. (1984) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1984.tb00121.x · Cited by 54
Barrou, Z., Guiban, D., Maroufi, A., Fournier, C., Dugué, M.-A., Luton, J.-P., & Thomopoulos, P. (1996) · European Journal of Endocrinology · doi:10.1530/eje.0.1340093 · Cited by 44
Mosnier-Pudar, H., Thomopoulos, P., Bertagna, X., Fournier, C., Guiban, D., & Luton, J. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1330313 · Cited by 43
Physiological and Pathological Variations in Saliva Cortisol
Guechot, J., Fiet, J., Passa, P., Villette, J. M., Gourmel, B., Tabuteau, F., Cathelineau, G., & Dreux, C. (1982) · Hormone Research · doi:10.1159/000179526 · Cited by 41
Hermus, A. R., Pieters, G. F., Borm, G. F., Verhofstad, A. A., Smals, A. G., Benraad, T. J., & Kloppenborg, P. W. (1993) · Acta Endocrinologica · doi:10.1530/acta.0.1280428 · Cited by 36
Advances in the diagnosis and treatment of Cushing's syndrome
Tsigos, C., Papanicolaou, D. A., & Chrousos, G. P. (1995) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(95)80354-8 · Cited by 30
Self-citationAmbrosi, B., Bochicchio, D., Ferrario, R., Colombo, P., & Faglia, G. (1989) · Journal of Endocrinological Investigation · doi:10.1007/bf03349913 · Cited by 27
Intermittent Hypercortisolism: A Disorder Strikingly Prevalent After Hypophysial Surgical Procedures
Streeten, D. H. P., Anderson, G. H., Dalakos, T. G., & Joachimpillai, A. D. (1997) · Endocrine Practice · doi:10.4158/ep.3.3.123 · Cited by 18
Misdiagnosis of Cushing's Syndrome in a Patient Receiving Rifampicin Therapy for Tuberculosis
Terzolo, M., Borretta, G., Alì, A., Cesario, F., Magro, G. G., Boccuzzi, A., Reimondo, G., & Angeli, A. (1995) · Hormone and Metabolic Research · doi:10.1055/s-2007-979927 · Cited by 17
Cited by
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718
Self-citationLacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Self-citationDiagnosis and complications of Cushing’s syndrome: a consensus statement
Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030871 · Cited by 1,362
“The mechanisms for these changes are probably multifactorial, 5598 J Clin Endocrinol Metab, December 2003, 88(12):5593–5602 Arnaldi et al.”
BackgroundInfluentialSelf-citationNewell-Price, J., Bertagna, X., Grossman, A. B., & Nieman, L. K. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68699-6 · Cited by 1,165
Self-citationMeasuring cortisol in human psychobiological studies
Levine, A., Zagoory-Sharon, O., Feldman, R., Lewis, J. G., & Weller, A. (2007) · Physiology & Behavior · doi:10.1016/j.physbeh.2006.08.025 · Cited by 472
Metadata
- Authors
- Papanicolaou, D. A., Mullen, N., Kyrou, I., & Nieman, L. K.
- Affiliations
- Emory University (US)
- National Institutes of Health (US)
- Corresponding author
- Nieman, Lynnette K.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2002-10
- Volume
- 87
- Issue
- 10
- Pages
- 4515-4521
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2089490142
- Cited by
- 241
- References
- 30
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 9 · 2023: 6 · 2022: 9 · 2021: 4 · 2020: 8 · 2019: 5 · 2018: 5 · 2017: 4 · 2016: 4 · 2015: 13 · 2014: 7 · 2013: 10 · 2012: 18
- FWCI
- 7.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Keywords
- Cushing's syndrome, salivary cortisol, screening test, diagnostic sensitivity, serum cortisol, dexamethasone suppression test, urine cortisol
- MeSH terms
- Adolescent, Adult, Aged, Circadian Rhythm, Cushing Syndrome, Female, Glucocorticoids, Humans, Hydrocortisone, Male, Middle Aged, Reference Values, Saliva, Sensitivity and Specificity, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.